Quantitative real-time PCR for detection of neurotoxin genes of Clostridium botulinum types A, B and C in equine samples.

This research examines a new method of detecting botulism in horses caused by Clostridium botulinum types A, B or C, by testing gastrointestinal, faecal and feed samples using a method called quantitative real-time PCR (qPCR). This methodology was compared to the standard mouse bioassay (MBA), showing higher sensitivity and specificity.

Optimization and Validation of qPCR for Botulism Detection in Horses

The main body of the research focused on improving and validating a detection system called quantitative real-time PCR (qPCR) for detecting the presence of botulism neurotoxin genes in horse samples. This included:

• Developing a duplex qPCR method for detecting C. botulinum types A and B.
• Setting up a singleplex qPCR method for the detection of C. botulinum type C.
• Optimizing these methods to work effectively with equine gastrointestinal, faecal and feed samples.

The duplex and the singleplex qPCR were used for simultaneous amplification and quantification of the figurative DNA sequence of the different toxins.

Performance Evaluation and Comparison with Standard Methods

Further into the research:

• The performance of the newly developed qPCR methods was evaluated using 148 well-characterized samples.
• Most of these samples were collected from a repository of veterinary diagnostic samples from cases of botulism, which included different types of C. botulinum (types A, B, C, D, and E).
• The findings from the qPCR methods were compared with the results of the standard mouse bioassay (MBA), which is commonly used for botulism detection.

Findings on Sensitivity and Specificity of qPCR and MBA

The research presented the following findings:

• The sensitivities, a measure of how correctly a test identifies positive cases, of the qPCR assays achieved were 89%, 86% and 96% for C. botulinum types A, B and C respectively.
• The overall sensitivity of the mouse bioassay for types A, B and C was found to be slightly lower, at 81%.
• The specificities, a measure of a test’s ability to correctly identify negative cases, of the qPCR assays were between 99-100%, whereas the mouse bioassay had a specificity of 95%.

These comparative performance results demonstrate the potential advantage of using qPCR for botulism detection in horses. The higher sensitivity means it is less likely to miss positive cases, and the higher specificity implies there will be fewer false positives when using the qPCR method.